• 1
    Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362: 17081709.
  • 2
    Kilander A, Rykkvin R, Dudman SG, Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009–2010. Euro Surveill 2010; 15: pii19498.
  • 3
    Chen H, Wen X, To KK et al. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis 2010; 201: 15171521.
  • 4
    Chan PK, Lee N, Joynt GM et al. Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus. J Clin Virol 2011; 50: 320324.
  • 5
    Miller RR, MacLean AR, Gunson RN, Carman WF. Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009–10. Euro Surveill 2010; 15: pii19546.
  • 6
    Mak GC, Au KW, Tai LS et al. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 2010; 15: pii19534.
  • 7
    Liu Y, Childs RA, Matrosovich T et al. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol 2010; 84: 1206912074.
  • 8
    Baldanti F, Campanini G, Piralla A et al. Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicentre study. Clin Microbiol Infect 2010; 17: 11661179.
  • 9
    Piralla A, Pariani E, Rovida F et al. Segregation of virulent influenza A(H1N1) variants in lower respiratory tract of critically ill patients during the 2010–2011 seasonal epidemic. PLoS One 2011; 6: e28332.
  • 10
    Ledesma J, Pozo F, Ruiz MP et al. Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain. J Clin Virol 2011; 51: 7578.
  • 11
    Ramakrishnan MA, Tu ZJ, Singh S et al. The feasibility of using high resolution genome sequencing of influenza A viruses to detect mixed infections and quasispecies. PLoS One 2009; 4: e7105.
  • 12
    Rozera G, Abbate I, Bruselles A et al. Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations. Retrovirology 2009; 6: 15.
  • 13
    Abbate I, Vlassi C, Rozera G et al. Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection. AIDS 2011; 25: 611617.
  • 14
    Ninomiya M, Ueno Y, Funayama R et al. Use of Illumina deep sequencing technology to differentiate hepatitis C virus variants. J Clin Microbiol 2012; 50: 857866.
  • 15
    Margeridon-Thermet S, Shulman NS, Ahmed A et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naïve patients. J Infect Dis 2009; 199: 12751285.
  • 16
    Kuroda M, Katano H, Nakajima N et al. Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One 2010; 5: e10256.
  • 17
    Bartolini B, Chillemi G, Abbate I et al. Assembly and characterization of pandemic influenza A H1N1 genome in nasopharyngeal swabs using high-throughput pyrosequencing. New Microbiol 2011; 34: 391397.
  • 18
    Ghedin E, Laplante J, DePasse J et al. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J Infect Dis 2011; 203: 168174.
  • 19
    Zarychanski R, Stuart TL, Kumar A et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182: 257264.
  • 20
    Simen BB, Simons JF, Hullsiek KH et al. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J Infect Dis 2009; 199: 693701.
  • 21
    Valli MB, Meschi S, Selleri M et al. Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. PLoS Curr 2010; 2: RRN1149.
  • 22
    Drews SJ, Pabbaraju K, Wong S et al. Surveillance of autopsy cases for D222G substitutions in haemagglutinin of the pandemic (H1N1) 2009 virus in Alberta, Canada. Clin Microbiol Infect 2011; 17: 582584.
  • 23
    Wang B, Dwyer DE, Soedjono M et al. Evidence of the circulation of pandemic influenza (H1N1) 2009 with D222D/G/N/S hemagglutinin polymorphisms during the first wave of the 2009 influenza pandemic. J Clin Virol 2011; 52: 304306.
  • 24
    Yasugi M, Nakamura S, Daidoji T et al. Frequency of D222G and Q223R hemagglutinin mutants of pandemic (H1N1) 2009 influenza virus in Japan between 2009 and 2010. PLoS One 2012; 7: e30946.
  • 25
    Chutinimitkul S, Herfst S, Steel J et al. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 2010; 84: 1180211813.
  • 26
    Belser JA, Jayaraman A, Raman R et al. Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virus. PLoS One 2011; 6: e25091.
  • 27
    Henn MR, Boutwell CL, Charlebois P et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 2012; 8: e1002529.
  • 28
    Tapparel C, Cordey S, Junier T et al. Rhinovirus genome variation during chronic upper and lower respiratory tract infections. PLoS One 2011; 6: e21163.